Rockwell Medical Company Profile (NASDAQ:RMTI)

Analyst Ratings

Consensus Ratings for Rockwell Medical (NASDAQ:RMTI) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 1.83)
Consensus Price Target: $10.60 (32.83% upside)

Analysts' Ratings History for Rockwell Medical (NASDAQ:RMTI)
Show:
DateFirmActionRatingPrice TargetActions
4/6/2016Morgan StanleyReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Bank of America Corp.Reiterated RatingNeutral$18.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016Craig HallumDowngradeBuy -> Hold$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Oppenheimer Holdings Inc.Reiterated RatingOutperform$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2015Brean CapitalReiterated RatingSell$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2015Summer StreetSet Price TargetPositive -> Buy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2014Chardan CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2014ING GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014FBR & CoInitiated CoverageUnderperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Rockwell Medical (NASDAQ:RMTI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/10/2016Q1($0.08)($0.10)$15.25 million$13.63 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q4$0.02($0.12)$19.98 million$14.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.02)($0.05)$14.93 million$14.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.10)($0.05)$11.84 million$12.96 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q414($0.10)($0.07)$13.20 million$13.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q4($0.10)($0.14)$13.51 million$14.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.10)($0.10)$13.40 million$13.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q2($0.13)($0.08)$13.45 million$13.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q1($0.14)($0.20)$14.22 million$13.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014($0.28)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.50)($0.86)$12.57 million$12.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rockwell Medical (NASDAQ:RMTI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.09)($0.09)($0.09)
Q2 20161($0.06)($0.06)($0.06)
Q3 20161($0.05)($0.05)($0.05)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Rockwell Medical (NASDAQ:RMTI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Rockwell Medical (NASDAQ:RMTI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/4/2015Ronald D. BoydDirectorSell12,500$10.58$132,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Robert L ChioiniCEOBuy4,910$11.96$58,723.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Raymond Dennis PrattVPBuy5,000$11.54$57,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Robert L ChioiniCEOBuy5,090$11.51$58,585.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2012David A HagelsteinMajor ShareholderBuy7,000$8.10$56,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Rockwell Medical (NASDAQ:RMTI)
DateHeadline
07/22/16 09:06 AMRockwell Medical Inc (NASDAQ:RMTI) Stock Volatility Hits A Lowered Level - CML News
07/21/16 09:01 AMWhat Next for Rockwell Medical Inc Stock After Today's Huge Increase? - Press Telegraph
07/21/16 09:01 AMEquity Roundup: Stock Performance Focus on Rockwell Medical, Inc. (NASDAQ:RMTI) - Press Telegraph
07/21/16 09:01 AMRockwell Medical Inc Stock Technicals at Critical Inflection Point - CML News
07/19/16 06:18 PMEarnings Focus and Crowd Sourced Sentiment Review for Rockwell Medical, Inc. (NASDAQ:RMTI) - TGP
07/19/16 06:18 PMRockwell Medical, Inc. (NASDAQ:RMTI) Expected To Post Sales Of $147.276 - Investor Newswire
07/19/16 07:08 AMShare Performance Summary for: Rockwell Medical, Inc. (NASDAQ:RMTI) - Press Telegraph
07/19/16 07:08 AMIs $7 Price Target Attainable For Rockwell Medical, Inc. (NASDAQ:RMTI)? - Investor Newswire
07/17/16 05:34 PMShares Experiencing a Downtrend: Rockwell Medical, Inc. (NASDAQ:RMTI) - TGP
07/17/16 05:34 PMRockwell Medical, Inc. (RMTI) Current Analyst Ratings - Fiscal Standard
07/15/16 11:22 AMRockwell Medical, Inc. (NASDAQ:RMTI) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 11:22 AMRockwell Medical, Inc. (NasdaqGM:RMTI) Fundamental Star Rating Report - CML News
07/13/16 09:04 AMRockwell Medical, Inc. (NASDAQ:RMTI) Yearly Sales Target At $147.276 - Investor Newswire
07/12/16 10:33 AMRockwell Medical, Inc. (NASDAQ:RMTI) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 10:33 AMStrong Sell Calls For Rockwell Medical, Inc. (NASDAQ:RMTI) At 2 - Investor Newswire
07/11/16 10:48 AMNext Weeks Broker Price Targets For Rockwell Medical, Inc. (RMTI) - Fiscal Standard
07/09/16 09:15 AMInstitutional Investors Are Buying Rockwell Medical Inc (NASDAQ:RMTI) - Press Telegraph
07/07/16 06:15 PMCompany Stock Focus for Rockwell Medical, Inc. (NASDAQ:RMTI): Which Way Will Shares Head? - Press Telegraph
07/07/16 06:15 PMNew Broker Ratings For Rockwell Medical, Inc. (RMTI) - FTSE News
07/06/16 06:28 PMSales of $147.276 expected for Rockwell Medical, Inc. (NASDAQ:RMTI) - Investor Newswire
07/06/16 06:28 PMRockwell Medical Inc. (RMTI) Jumps 5.42% on July 04 - Equities.com
07/06/16 06:28 PMRockwell Medical Inc. (RMTI) Drops 5.89% on July 05 - Equities.com
07/05/16 05:52 PMRockwell Medical, Inc. (NASDAQ:RMTI) Expected to Reach Highs Of $9 - Investor Newswire
07/05/16 05:52 PMShare Performance Recap for: Rockwell Medical, Inc. (NASDAQ:RMTI) - Press Telegraph
07/05/16 05:52 PMBroker Outlook For The Week Ahead Rockwell Medical, Inc. (RMTI) - Fiscal Standard
06/28/16 10:57 AMRockwell Medical, Inc. (RMTI) Updated Price Targets - FTSE News
06/27/16 06:04 PMRockwell Medical, Inc. (RMTI) Broker Price Targets For The Coming Week - Fiscal Standard
06/27/16 06:04 PMStrong Sell Calls Recommendations For Rockwell Medical, Inc. (NASDAQ:RMTI) At 2 - Investor Newswire
06/25/16 09:52 AMRockwell Medical, Inc. (NASDAQ:RMTI) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 03:02 PMROCKWELL MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers -
06/23/16 08:50 AMRockwell Medical Inc. (RMTI) is Trading Lower on Unusual Volume for June 21 - Equities.com
06/23/16 08:50 AMRockwell Medical Inc. (RMTI) Drops 5.3% on June 21 - Equities.com
06/23/16 07:39 AMRockwell Medical Announces Appointment of Dr. Robin Smith to Board of Directors - [at noodls] - June 23, 2016 WIXOM, Mich., June 23, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney ...
06/22/16 10:53 AMRockwell Medical, Inc. (NASDAQ:RMTI) Yearly Sales Projections At $147.276 - Investor Newswire
06/21/16 05:42 PMRockwell Medical, Inc. (NasdaqGM:RMTI) Stock Momentum Hits Weakness - CML News
06/21/16 10:30 AMStrong Buy Calls Count For Rockwell Medical, Inc. (NASDAQ:RMTI) At 0 - Investor Newswire
06/20/16 02:46 PMRockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : June 20, 2016 -
06/20/16 07:43 AMRockwell Medical, Inc. (RMTI) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 10:17 AMStock to Watch: Rockwell Medical Inc (NASDAQ:RMTI - iStreetWire
06/14/16 07:46 AMRockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : June 14, 2016 -
06/07/16 06:24 PMROCKWELL MEDICAL INC. (NASDAQ:RMTI) Financial Condition Compared to S&P 500 - CML News
06/06/16 06:06 PMCan Rockwell Medical, Inc. (NASDAQ:RMTI) Keep Up with Analyst Expectations? - Investor Newswire
06/06/16 04:06 PMROCKWELL MEDICAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/04/16 09:07 AMOverview of Analyst's Recommendations: Rockwell Medical, Inc. (NASDAQ:RMTI) , Idera Pharmaceuticals, Inc ... - Street Updates
06/03/16 02:38 PMETF’s with exposure to Rockwell Medical, Inc. : June 3, 2016 -
06/02/16 09:11 AMRockwell Medical, Inc. (RMTI) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Rockwell Medical, Inc. (RMTI) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Rockwell Medical, Inc. (RMTI). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...Rockwell Medical Incorporated (NASDAQ:RMTI) Shorted Shares Increased By 0.5%The PostRockwell Medical, Inc. (RMTI) Updated Analyst CoverageRisers & Fallersall 4 news articles »
05/31/16 06:29 PMRockwell Medical, Inc. (NASDAQ:RMTI) Stock Update & Estimates - Stock Tick Tock - Rockwell Medical, Inc. (NASDAQ:RMTI) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Rockwell Medical, Inc. (NASDAQ:RMTI) to post earnings of $-0.12 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued ...and more »
05/30/16 02:43 PMRockwell Medical, Inc. (RMTI) Broker Price Targets For The Coming Week - Share Trading News - Rockwell Medical, Inc. (RMTI) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Rockwell Medical, Inc. (RMTI). The latest reports which are currently in issue on Monday 30th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/27/16 07:54 PMRockwell Medical, Inc. (NASDAQ:RMTI) Closes At $9.27 - Investor Newswire - Rockwell Medical, Inc. (NASDAQ:RMTI) Closes At $9.27Investor NewswireYesterday, the stock of Rockwell Medical, Inc. (NASDAQ:RMTI) closed at $9.27 after opening at $9.28 and registering high of $9.51 and low of $9.24. The last price is $-9.51 off 1-year high of $18.90 and $3.92 away from low of $5.47 during same period.and more »
05/26/16 01:02 AMBroker Roundup For Rockwell Medical, Inc. (RMTI) - Share Trading News - Broker Roundup For Rockwell Medical, Inc. (RMTI)Share Trading News05/14/2014 – Rockwell Medical, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of Rockwell Medical, Inc. (RMTI) was up +2.03% during the last trading session, with a day high of 9.73. 302041 shares were traded on Rockwell ...

Social

About Rockwell Medical

Rockwell Medical logoRockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its lead branded drug, Triferic is indicated for iron maintenance. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Its generic drug, Calcitriol, is indicated for treating secondary hyperparathyroidism in dialysis patients. It manufactures, sells, delivers and distributes hemodialysis concentrates, along with a range of ancillary products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: RMTI
  • CUSIP: 77437410
Key Metrics:
  • Previous Close: $7.98
  • 50 Day Moving Average: $8.12
  • 200 Day Moving Average: $7.81
  • P/E Ratio: N/A
  • P/E Growth: -1.48
  • Market Cap: $411.18M
  • Beta: 1.78
  • Current Year EPS Consensus Estimate: $-0.29 EPS
  • Next Year EPS Consensus Estimate: $-0.01 EPS
Additional Links:
Rockwell Medical (NASDAQ:RMTI) Chart for Saturday, July, 23, 2016